Xtant Medical Holdings (XTNT) Long-Term Investments (2010 - 2018)
Xtant Medical Holdings' (XTNT) quarterly Long-Term Investments came in at $138000.0 in Q1 2018, down 68.7% year-over-year from $440853.0 in Q1 2017, and down 28.87% quarter-over-quarter from $194000.0 in Q4 2017.
Analysis
Xtant Medical Holdings (XTNT) Long-Term Investments (2010 - 2018) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Long-Term Investments for 9 consecutive years, with $138000.0 the latest figure, recorded in Q1 2018.
- On a quarterly basis, Long-Term Investments fell 68.7% year-over-year to $138000.0 in Q1 2018; TTM through Mar 2018 was $138000.0, a 68.7% decrease from a year earlier, with the FY2017 full-year figure at $194000.0, down 80.04% from the prior year.
- Long-Term Investments was $138000.0 for Q1 2018 at Xtant Medical Holdings, down from $194000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $2.1 million in Q1 2014 and troughed at $138000.0 in Q1 2018.
- A 5-year average of $1.3 million and a median of $1.5 million in 2016 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments jumped 67.15% in 2014 and sank 80.04% in 2017, its largest moves.
- Over 5 years, Long-Term Investments stood at $1.9 million in 2014, then fell by 16.87% to $1.6 million in 2015, then slumped by 39.56% to $971854.0 in 2016, then slumped by 80.04% to $194000.0 in 2017, then slipped by 28.87% to $138000.0 in 2018.
- The last three Long-Term Investments figures came in at $138000.0 (Q1 2018), $194000.0 (Q4 2017), and $717817.0 (Q3 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 138,000.00 |
| Dec 31, 2017 | 194,000.00 |
| Sep 30, 2017 | 717,817.00 |
| Jun 30, 2017 | 641,124.00 |
| Mar 31, 2017 | 440,853.00 |
| Dec 31, 2016 | 971,854.00 |
| Sep 30, 2016 | 1.27 Mn |
| Jun 30, 2016 | 1.48 Mn |
| Mar 31, 2016 | 1.44 Mn |
| Dec 31, 2015 | 1.61 Mn |
| Sep 30, 2015 | 1.68 Mn |
| Jun 30, 2015 | 1.84 Mn |
| Mar 31, 2015 | 1.79 Mn |
| Dec 31, 2014 | 1.93 Mn |
| Jun 30, 2014 | 1.83 Mn |
| Mar 31, 2014 | 2.07 Mn |
| Dec 31, 2013 | 2.12 Mn |
| Sep 30, 2013 | 1.24 Mn |
| Jun 30, 2013 | 1.24 Mn |
| Mar 31, 2013 | 1.24 Mn |